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Background: Omega-3 fatty acids have demonstrated a positive impact on mortality in randomized trials. Supplements of decosahexanoic acid 
(DHA) and eicosapentanoic acid (EPA), the main components of Omega 3, have been shown to reduce total and cardiovascular (CV) mortality. 
Omega-3 values, DHA and EPA may represent potential markers for predicting risk of death.
Methods: The SADHART-CHF trial was a randomized, double-blind trial of sertraline or placebo in 469 pts with HF (LVEF ≤45% and NYHA class ≥ II) 
and clinical depression. Plasma samples were obtained from patients who consented to the biomarker substudy. Plasma phospholipid EPA and DHA, 
Omega-3, and Omega-6 values were analyzed using unadjusted Cox proportional hazards regression modeling of survival.
Results: 109 patient samples were included in this analysis. 
N=109 Hazard Ratio (95% CI) p-value
Omega 3 Proportion 0.93 (0.82-1.04) 0.14
Plasma Phospholipid EPA + DHA 0.64 (0.42-0.99) 0.02
Total Omega 3 0.65 (0.43-0.98) 0.02
Total Omega 6 0.96 (0.81-1.15) 0.69
Omega 6 / Omega 3 1.18 (0.99-1.40) 0.07
DHA 0.67 (0.43-1.05) 0.06
EPA (HR per .1 unit change) 0.73 (0.56-0.96) 0.005
Conclusions: There was a significant association with survival for total Omega-3, plasma phospholipid EPA + DHA, and EPA values. DHA showed 
an association with lower mortality but did not reach statistical significance. These data suggest that Omega-3 and plasma phospholipid EPA + DHA 
may be predictors for risk of death in depressed heart failure patients.
